Citations (103)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sourav Bhattacharjee & David J. Brayden. (2021) Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients. Expert Opinion on Drug Discovery 16:3, pages 235-254.
Read now
Read now
Kyungmin Lee, Asima Bajwa, Clovis A Freitas-Neto, Jamie Lynne Metzinger, Bailey A Wentworth & C Stephen Foster. (2014) A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I. Expert Opinion on Pharmacotherapy 15:15, pages 2141-2154.
Read now
Read now
Sonali S Bharate & Ram A Vishwakarma. (2013) Impact of preformulation on drug development. Expert Opinion on Drug Delivery 10:9, pages 1239-1257.
Read now
Read now
D.R.J. Kuypers. (2007) KIDNEY TRANSPLANTATION: CURRENT ISSUES AND FUTURE PROSPECTS. Acta Clinica Belgica 62:4, pages 208-217.
Read now
Read now
Ali J Olyaei, Angelo M deMattos & William M Bennett. (2005) Cardiovascular complications of immunosuppressive agents in renal transplant recipients. Expert Opinion on Drug Safety 4:1, pages 29-44.
Read now
Read now
Articles from other publishers (98)
Weiye Li & Jingfa Zhang. 2024. Therapeutic Targets for Diabetic Retinopathy. Therapeutic Targets for Diabetic Retinopathy
113
143
.
Bernardo Cortese, Harkaran Kalkat, Gurbir Bathia & Sandeep Basavarajaiah. (2023) The evolution and revolution of drug coated balloons in coronary angioplasty: An up‐to‐date review of literature data. Catheterization and Cardiovascular Interventions 102:6, pages 1069-1077.
Crossref
Crossref
Dong-Ho Nahm. (2023) Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives. Life 13:8, pages 1674.
Crossref
Crossref
Yuanchao Jia, Yuxin Jiang, Yonglong He, Wanting Zhang, Jiahui Zou, Kosheli Thapa Magar, Hamza Boucetta, Chao Teng & Wei He. (2023) Approved Nanomedicine against Diseases. Pharmaceutics 15:3, pages 774.
Crossref
Crossref
Matteo Zurlo, Francesco Nicoli, Davide Proietto, Beatrice Dallan, Cristina Zuccato, Lucia Carmela Cosenza, Jessica Gasparello, Chiara Papi, Elisabetta d'Aversa, Monica Borgatti, Chiara Scapoli, Alessia Finotti & Roberto Gambari. (2023)
Effects of Sirolimus treatment on patients with
β‐Thalassemia
: Lymphocyte immunophenotype and biological activity of memory
CD4
+
and
CD8
+
T cells
. Journal of Cellular and Molecular Medicine 27:3, pages 353-364.
Crossref
Crossref
Swapnil Salvi, Ankur Jain, Giuseppe Pontrelli & Sean McGinty. (2022) Modeling Dual Drug Delivery from Eluting Stents: The Influence of Non-Linear Binding Competition and Non-Uniform Drug Loading. Pharmaceutical Research 40:1, pages 215-230.
Crossref
Crossref
Karan L. Chohan, Jithma P. Abeykoon, Jason R. Young, W. Oliver Tobin, Mathew J. Koster, Mithun V. Shah, Jay H. Ryu, Robert Vassallo, Karen L. Rech.Aishwarya Ravindran, Gaurav Goyal, Ronald S. Go & N. Nora Bennani. (2022) Sirolimus as frontline therapy for <i>PTEN</i>-mutated histiocytic sarcoma. Haematologica 108:6, pages 1702-1706.
Crossref
Crossref
David M. Sayah & Joseph M. Pilewski. (2022) Outpatient Pharmacologic Management of Lung Transplant Candidates on the Waiting List. Thoracic Surgery Clinics 32:2, pages 111-119.
Crossref
Crossref
Yu-Ting Lin, Chia-Ling Yu, Yu-Kang Tu & Ching-Chi Chi. (2022) Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis. Biomedicines 10:4, pages 826.
Crossref
Crossref
Pedro Javier Salas-AmbrosioMaría Josefa Bernad-BernadMónica Anayántzin Linares-AlbaRodrigo García-SantistebanLuis Angel Tonix-AburtoGuadalupe Jocelyn Ornelas-LobatoIsabel Gracia-MoraMarisol Rivera-HuertaFrancisco Sánchez-BartezHéctor Rico-MoralesGustavo Adolfo García-Sánchez. (2021) Toxicity Evaluation of a Novel Rapamycin Liposomal Formulation After Subconjunctival and Intravitreal Injection. Journal of Ocular Pharmacology and Therapeutics 37:5, pages 261-276.
Crossref
Crossref
Stephani C. Wang, Eugene Pashkovetsky, David Conti, Ashar Ata, Mikhail Torosoff, Steven Fein, Nikolaos Chandolias, Reynold I. Lopez-Soler & Radmila Lyubarova. (2021) Pericardial Effusion After Renal Transplantation: Timing and Clinical Characteristics. Transplantation Proceedings 53:5, pages 1606-1610.
Crossref
Crossref
Eline S. Zwart, Esen Yüksel, Anne Pannekoek, Ralph de Vries, Reina E. Mebius & Geert Kazemier. (2021) De Novo Carcinoma after Solid Organ Transplantation to Give Insight into Carcinogenesis in General—A Systematic Review and Meta-Analysis. Cancers 13:5, pages 1122.
Crossref
Crossref
Yi Hsuan LiShiuh-Liang HsuShwu-Jiuan Sheu. (2021) A Review of Local Therapy for the Management of Cystoid Macular Edema in Uveitis. Asia-Pacific Journal of Ophthalmology 10:1, pages 87-92.
Crossref
Crossref
Sasidharan L. Sreejith, Babu P. Aswathy, Roy Joseph & Renjith Sasi. (2020) Size exclusion chromatography: An effective tool for the estimation of Sirolimus levels. Journal of Chromatography B 1156, pages 122303.
Crossref
Crossref
Kevin Groudan, Khalid Sawalha, Anusha G Bhat, Ahmed Eltanbedawi & Paurush Ambesh. (2020) Hemopericardium in a Sirolimus-Treated Renal Transplant Patient. Cureus.
Crossref
Crossref
Robert M. Stern & Nancy Berliner. (2019) Targeting the mTOR pathway in idiopathic multicentric Castleman disease. Journal of Clinical Investigation 129:10, pages 4086-4088.
Crossref
Crossref
Joseph Lopez, Christine G. Gourin & Anthony P. Tufaro. (2019) Aggressive Cutaneous Malignancies: A New and Dangerous Phenomenon in Transplant Patients. Current Surgery Reports 7:1.
Crossref
Crossref
Naoaki Sakata, Gumpei Yoshimatsu & Shohta Kodama. (2018) The Spleen as an Optimal Site for Islet Transplantation and a Source of Mesenchymal Stem Cells. International Journal of Molecular Sciences 19:5, pages 1391.
Crossref
Crossref
Metka Benčina, Tina Mavrič, Ita Junkar, Aleksander Bajt, Aleksandra Krajnović, Katja Lakota, Polona Žigon, Snežna Sodin-Šemrl, Veronika Kralj-Iglič & Aleš Iglič. 2018.
115
165
.
P. Marquet & A. Åsberg. 2017. Individualized Drug Therapy for Patients. Individualized Drug Therapy for Patients
255
279
.
Marek Drozdzik. 2017. Kidney Transplantation, Bioengineering and Regeneration. Kidney Transplantation, Bioengineering and Regeneration
429
443
.
Youngseok Cho, Eun-Sol Ha, In-Hwan Baek, Min-Soo Kim, Cheong-Weon Cho & Sung-Joo Hwang. (2015) Enhanced Supersaturation and Oral Absorption of Sirolimus Using an Amorphous Solid Dispersion Based on Eudragit® E. Molecules 20:6, pages 9496-9509.
Crossref
Crossref
Luciana TM Saturnino, Maria GB Ceccato, Mariangela L Cherchiglia, Eli lola G Andrade, Luiz Flavio C Giordano & Francisco A Acurcio. (2015) Target of rapamycin inhibitors (TORi) as maintenance immunosuppression for kidney transplant recipients. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Geraldine R. Slean & Rahul N. Khurana. (2015) Local Therapeutic Options for Uveitic Cystoid Macular Edema. International Ophthalmology Clinics 55:3, pages 39-61.
Crossref
Crossref
Eunbi Kim, Sam Young Yoon & Young Joo Shin. 2015. Studies on the Cornea and Lens. Studies on the Cornea and Lens
3
22
.
Hongling Liu, Yanyan Zhang, Haiyan Ma, Chunmei Zhang & Shaoying Fu. (2014) Comparison of posterior capsule opacification in rabbit eyes receiving different administrations of rapamycin. Graefe's Archive for Clinical and Experimental Ophthalmology 252:7, pages 1111-1118.
Crossref
Crossref
Kathrin Welzl, Georg Kern, Gert Mayer, Birgit Weinberger, Marcus D. Säemann, Gisela Sturm, Beatrix Grubeck-Loebenstein & Christian Koppelstaetter. (2014) Effect of Different Immunosuppressive Drugs on Immune Cells from Young and Old Healthy Persons. Gerontology 60:3, pages 229-238.
Crossref
Crossref
Joshua K. Salabei & Bradford G. Hill. (2013) Implications of autophagy for vascular smooth muscle cell function and plasticity. Free Radical Biology and Medicine 65, pages 693-703.
Crossref
Crossref
Rajesh Thipparaboina, Wahid Khan & Abraham J. Domb. (2013) Eluting combination drugs from stents. International Journal of Pharmaceutics 454:1, pages 4-10.
Crossref
Crossref
Ka Wai Mok, Dolores D. Mruk & C. Yan Cheng. 2013.
291
358
.
Volker Neu, Nathanaël Delmotte, Uwe Kobold, Thomas Dülffer, Rupert Herrmann, Herbert von der Eltz & Christian G. Huber. (2012) On-line solid-phase extraction high-performance liquid chromatography-tandem mass spectrometry for the quantitative analysis of tacrolimus in whole blood hemolyzate. Analytical and Bioanalytical Chemistry 404:3, pages 863-874.
Crossref
Crossref
Itay Shalev, Nazia Selzner, Wendy Shyu, David Grant & Gary Levy. (2012) Role of regulatory T cells in the promotion of transplant tolerance. Liver Transplantation 18:7, pages 761-770.
Crossref
Crossref
L Johnston, M Florek, R Armstrong, J S McCune, S Arai, J Brown, G Laport, R Lowsky, D Miklos, J Shizuru, K Sheehan, P Lavori & R Negrin. (2011) Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation. Bone Marrow Transplantation 47:4, pages 581-588.
Crossref
Crossref
Andrew J. Ro, Robert Falotico & Vipul Davé. (2011)
Morphological and degradation studies of sirolimus‐containing poly(lactide‐
co
‐glycolide) discs
. Journal of Biomedical Materials Research Part B: Applied Biomaterials 100B:3, pages 767-777.
Crossref
Crossref
Luciana TM Saturnino, Maria GB Ceccato, Mariangela L Cherchiglia, Eli lola G Andrade, Luiz Flavio C Giordano & Francisco A Acurcio. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
E.L.D. de Mare-Bredemeijer & H.J. Metselaar. (2012) Optimization of the use of Calcineurin inhibitors in liver transplantation. Best Practice & Research Clinical Gastroenterology 26:1, pages 85-95.
Crossref
Crossref
Bertram L. Kasiske, Bjorn Nashan, Maria Del Carmen Rial, Pablo Raffaele, Graeme Russ, Josep Campistol, Mark D. Pescovitz & Paul A. Keown. (2012) A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation. Journal of Transplantation 2012, pages 1-16.
Crossref
Crossref
Peter F. Hoyer. (2011) Late withdrawal of calcineurin inhibitors and switch to mTOR inhibitors – beneficial or too late?. Pediatric Transplantation 15:8, pages 767-769.
Crossref
Crossref
Debasmita Roy & Dirk P. Dittmer. (2011) Phosphatase and Tensin Homolog on Chromosome 10 Is Phosphorylated in Primary Effusion Lymphoma and Kaposi's Sarcoma. The American Journal of Pathology 179:4, pages 2108-2119.
Crossref
Crossref
Tarek A.N. Ahmed, Sandrin C. Bergheanu, Theo Stijnen, Josepha W.M. Plevier, Paul H.A. Quax & J. Wouter Jukema. (2011) Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review. EuroIntervention 7:4, pages 505-516.
Crossref
Crossref
John Vassiliadis, Christina Bracken, Douglas Matthews, Stephen O'Brien, Susan Schiavi & Stefan Wawersik. (2011) Calcium Mediates Glomerular Filtration through Calcineurin and mTORC2/Akt Signaling. Journal of the American Society of Nephrology 22:8, pages 1453-1461.
Crossref
Crossref
Devon D. Egenolf, Patricia Rafferty, Kerry Brosnan, Mindi Walker, Jarrat Jordan, Dorie Makropoulos, Karl Kavalkovich, Sharon Watson, Laura Johns, Amy Volk & Peter J. Bugelski. (2011) Development of a murine model of lymph node metastases suitable for immunotoxicity studies. Journal of Pharmacological and Toxicological Methods 63:3, pages 236-249.
Crossref
Crossref
Miodrag C. Ostojic, Zoran Perisic, Dragan Sagic, Robert Jung, Yan-Ling Zhang, Jamie Bendrick-Peart, Ronald Betts & Uwe Christians. (2010) The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: The Stealth PK Study. European Journal of Clinical Pharmacology 67:4, pages 389-398.
Crossref
Crossref
Andrew J. Ro, Robert Falotico & Vipul Davé. (2011)
Microstructure and drug‐release studies of sirolimus‐containing poly(lactide‐
co
‐glycolide) films
. Journal of Biomedical Materials Research Part B: Applied Biomaterials 97B:1, pages 30-39.
Crossref
Crossref
Wolfgang Steudel, Colleen Dingmann, Yan-Ling Zhang, Jamie Bendrick-Peart, Claudia Clavijo, John Shulze, Ronald Betts & Uwe Christians. (2011) Randomized, Double-Blind, Placebo-Controlled, Single Intravenous Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of the Novel Coronary Smooth Muscle Cell Proliferation Inhibitor Biolimus A9 in Healthy Individuals. The Journal of Clinical Pharmacology 51:1, pages 29-39.
Crossref
Crossref
Henk-Jan Schuurman. 2011. Principles of Immunopharmacology. Principles of Immunopharmacology
525
556
.
Hulya Ozturk, Akan Terzi, Hayrettin Ozturk & Aysel Kukner. (2010) Effect of sirolimus on renal injury induced by bile duct ligation in rats. Acta Cirurgica Brasileira 25:5, pages 401-406.
Crossref
Crossref
Yuan-Xing Liu, Li-Ming Jin, Lin Zhou, Hai-Yang Xie, Guo-Ping Jiang, Hui Chen & Shu-Sen Zheng. (2009) Sirolimus Attenuates Reduced-Size Liver Ischemia–Reperfusion Injury But Impairs Liver Regeneration in Rats. Digestive Diseases and Sciences 55:8, pages 2255-2262.
Crossref
Crossref
Dominique Aubel & Martin Fussenegger. (2010) Mammalian synthetic biology - from tools to therapies. BioEssays 32:4, pages 332-345.
Crossref
Crossref
F. Cicora, N. Lausada, D.N. Vasquez, P. Cicora, G. Zalazar, P. Gonzalez, G. Palti & C. Raimondi. (2010) Sirolimus in Kidney Transplant Donors and Clinical and Histologic Improvement in Recipients: Rat Model. Transplantation Proceedings 42:1, pages 365-370.
Crossref
Crossref
Mark D. Pescovitz, Nosratollah Nezakatgoo, Marc I. Lorber, Bjorn Nashan, Helio Tedesco-Silva, Bertram L. Kasiske, Federico J. Juarez de la Cruz, Graeme Russ, Joseph Campistol & Paul A. Keown. (2009) Prospective Observational Study of Sirolimus as Primary Immunosuppression After Renal Transplantation. Transplantation 88:8, pages 1010-1018.
Crossref
Crossref
Kam Hon Yoon. (2009) Proliferation Signal Inhibitors for the Treatment of Refractory Autoimmune Rheumatic Diseases. Annals of the New York Academy of Sciences 1173:1, pages 752-756.
Crossref
Crossref
Beate Vollenbröker, Britta George, Maria Wolfgart, Moin A. Saleem, Hermann Pavenstädt & Thomas Weide. (2009) mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes. American Journal of Physiology-Renal Physiology 296:2, pages F418-F426.
Crossref
Crossref
Jost Klawitter, Jamie Bendrick-Peart, Birgit Rudolph, Virginia Beckey, Jelena Klawitter, Manuel Haschke, Christopher Rivard, Laurence Chan, Dieter Leibfritz, Uwe Christians & Volker Schmitz. (2008) Urine Metabolites Reflect Time-Dependent Effects of Cyclosporine and Sirolimus on Rat Kidney Function. Chemical Research in Toxicology 22:1, pages 118-128.
Crossref
Crossref
Miodrag Ostojic, Dragan Sagic, Robert Jung, Yan‐Ling Zhang, Milan Nedeljkovic, Ljupco Mangovski, Sinisa Stojkovic, Dragan Debeljacki, Mirko Colic, Branko Beleslin, Bratislav Milosavljevic, Dejan Orlic, Dragan Topic, Nevena Karanovic, Dragica Paunovic & Uwe Christians. (2008) The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: The NOBORI PK study. Catheterization and Cardiovascular Interventions 72:7, pages 901-908.
Crossref
Crossref
Gian Marco Ghiggeri, Maurizio Bruschi, Luca Musante, Giovanni Candiano, Claudia Boccardi, Lorenzo Citti, Maria Pia Rastaldi, Salvatore Mangraviti, Giuseppina Rosso, Aida Larti, Alberto Rosati, Andrea Urbani, Rosanna Gusmano, Elisabetta Bertoni & Maurizio Salvadori. (2008) Post‐transplant proteinuria associated with everolimus: Definition of main features with proteomics. PROTEOMICS – Clinical Applications 2:9, pages 1327-1337.
Crossref
Crossref
S. L. Lui, R. Tsang, K. W. Chan, F. Zhang, S. Tam, S. Yung & T. M. Chan. (2008) Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice. Nephrology Dialysis Transplantation 23:9, pages 2768-2776.
Crossref
Crossref
SL Lui, S Yung, R Tsang, F Zhang, KW Chan, S Tam & TM Chan. (2008)
Rapamycin prevents the development of nephritis in lupus-prone NZB/W F
1
mice
. Lupus 17:4, pages 305-313.
Crossref
Crossref
Tobin Strom, Manuel Haschke, Jared Boyd, Mark Roberts, Lili Arabshahi, Peter Marbach & Uwe Christians. (2007) Crossreactivity of Isolated Everolimus Metabolites With the Innofluor Certican Immunoassay for Therapeutic Drug Monitoring of Everolimus. Therapeutic Drug Monitoring 29:6, pages 743-749.
Crossref
Crossref
Gary Levy, Heinz Schmidli, Jeffrey Punch, Elizabeth Tuttle-Newhall, David Mayer, Peter Neuhaus, Didier Samuel, Bjorn Nashan, Juergen Klempnauer, Alan Langnas, Yvon Calmus, Xavier Rogiers, Michael Abecassis, Richard Freeman, Maarten Sloof, John Roberts & Lutz Fischer. (2006) Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. Liver Transplantation 12:11, pages 1640-1648.
Crossref
Crossref
Sing Leung Lui, Kwok Wah Chan, Ryan Tsang, Susan Yung, Kar Neng Lai & Tak Mao Chan. (2006) Effect of rapamycin on renal ischemia-reperfusion injury in mice. Transplant International 19:10, pages 834-839.
Crossref
Crossref
Angela C Webster, Vincent WS Lee, Jeremy R Chapman & Jonathan C Craig. (2006) Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Matin M. Imanguli, Steven Z. Pavletic, Jean-Pierre Guadagnini, Jaime S. Brahim & Jane C. Atkinson. (2006) Chronic graft versus host disease of oral mucosa: Review of available therapies. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 101:2, pages 175-183.
Crossref
Crossref
Burckhardt Ringe & Felix Braun. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
M. Boratyńska, M. Banasik, E. Wątorek, K. Falkiewicz, D. Patrzałek, P. Szyber & M. Klinger. (2006) Conversion to Sirolimus From Cyclosporine May Induce Nephrotic Proteinuria and Progressive Deterioration of Renal Function in Chronic Allograft Nephropathy Patients. Transplantation Proceedings 38:1, pages 101-104.
Crossref
Crossref
Joseph H. Antin. (2005) Approaches to graft-vs-host disease. Pediatric Transplantation 9, pages 71-75.
Crossref
Crossref
Yan Ling Zhang, Jamie Bendrick-Peart, Tobin Strom, Manuel Haschke & Uwe Christians. (2005) Development and Validation of a High-Throughput Assay for Quantification of the Proliferation Inhibitor ABT-578 Using LC/LC-MS/MS in Blood and Tissue Samples. Therapeutic Drug Monitoring 27:6, pages 770-778.
Crossref
Crossref
Julio Pascual, Roberto Marc??n & Joaqu??n Ortu??o. (2005) Clinical Experience with Everolimus (Certican): Optimizing Dose and Tolerability. Transplantation 79:Supplement 3, pages S80-S84.
Crossref
Crossref
Mai-Szu Wu, Chiz-Tzung Chang & Cheng-Chieh Hung. (2005) Rapamycin in patients with chronic renal allograft dysfunction. Clinical Transplantation 19:2, pages 236-242.
Crossref
Crossref
Bartosz Foroncewicz, Krzysztof Mucha, Leszek Paczek, Andrzej Chmura & Wojciech Rowinski. (2005) Efficacy of rapamycin in patient with juvenile rheumatoid arthritis. Transplant International 18:3, pages 366-368.
Crossref
Crossref
Shih-Chieh J. Chueh & Barry D. Kahan. (2005) Clinical application of sirolimus in renal transplantation: an update. Transplant International 18:3, pages 261-277.
Crossref
Crossref
J. Romagnoli, F. Citterio, G. Nanni, V. Tondolo & M. Castagneto. (2005) Severe Limb Lymphedema in Sirolimus-Treated Patients. Transplantation Proceedings 37:2, pages 834-836.
Crossref
Crossref
Laura J. Johnston, Janice Brown, Judith A. Shizuru, Keith E. Stockerl-Goldstein, Monic J. Stuart, Karl G. Blume, Robert S. Negrin & Nelson J. Chao. (2005) Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation 11:1, pages 47-55.
Crossref
Crossref
Marcus D. Saemann, Maximilian Zeyda, Thomas M. Stulnig, Georg A. Bohmig, Thomas Wekerle, Walter H. Horl & Gerhard J. Zlabinger. (2004) Janus kinase-3 (JAK3) inhibition: a novel immunosuppressive option for allogeneic transplantation. Transplant International 17:9, pages 481-489.
Crossref
Crossref
K. Budde, H.-H. Neumayer, G. Lehne, M. Winkler, I. A. Hauser, A. Lison, L. Fritsche, J.-P. Soulillou, P. Fauchald & J. Dantal. (2004) Tolerability and steady-state pharmacokinetics of everolimus in maintenance renal transplant patients. Nephrology Dialysis Transplantation 19:10, pages 2606-2614.
Crossref
Crossref
Marcus D. S�emann, Maximilian Zeyda, Thomas M. Stulnig, Georg A. B�hmig, Thomas Wekerle, Walter H. H�rl & Gerhard J. Zlabinger. (2004) Janus kinase-3 (JAK3) inhibition: a novel immunosuppressive option for allogeneic transplantation. Transplant International 17:9, pages 481-489.
Crossref
Crossref
Kathleen J. Smith, Sate Hamza & Henry Skelton. (2004) Histologic Features in Primary Cutaneous Squamous Cell Carcinomas in Immunocompromised Patients Focusing on Organ Transplant Patients. Dermatologic Surgery 30:4p2, pages 634-641.
Crossref
Crossref
Markus J. Barten, Frank Streit, Martin Boeger, Stefan Dhein, Attila Tarnok, Maria Shipkova, Victor W. Armstrong, Friedrich W. Mohr, Michael Oellerich & Jan F. Gummert. (2004) SYNERGISTIC EFFECTS OF SIROLIMUS WITH CYCLOSPORINE AND TACROLIMUS: ANALYSIS OF IMMUNOSUPPRESSION ON LYMPHOCYTE PROLIFERATION AND ACTIVATION IN RAT WHOLE BLOOD. Transplantation 77:8, pages 1154-1162.
Crossref
Crossref
KATHLEEN J. SMITH, SATE HAMZA & HENRY SKELTON. (2004) Histologic Features in Primary Cutaneous Squamous Cell Carcinomas in Immunocompromised Patients Focusing on Organ Transplant Patients. Dermatologic Surgery 30:4, Part 2, pages 634-641.
Crossref
Crossref
C Toniatti, H Bujard, R Cortese & G Ciliberto. (2004) Gene therapy progress and prospects: transcription regulatory systems. Gene Therapy 11:8, pages 649-657.
Crossref
Crossref
Eric Thervet, Frank Martinez & Christophe Legendre. (2004) Benefit-Risk Assessment of Ciclosporin Withdrawal in Renal Transplant Recipients. Drug Safety 27:7, pages 457-476.
Crossref
Crossref
Finsterer Josef, Kanzler Marina & Weinberger Alois. (2003) Sirolimus myopathy. Transplantation 76:12, pages 1773-1774.
Crossref
Crossref
William M. Bennett. (2003) Immunosuppression with Mycophenolic Acid: One Size Does Not Fit All. Journal of the American Society of Nephrology 14:9, pages 2414-2416.
Crossref
Crossref
Julian Gomez-Cambronero. (2003) Rapamycin inhibits GM-CSF-induced neutrophil migration. FEBS Letters 550:1-3, pages 94-100.
Crossref
Crossref
Johannes Donauer, Brigitta Rumberger, Marinella Klein, Daniel Faller, Jochen Wilpert, Titus Sparna, Gisela Schieren, Rolf Rohrbach, Peter Dern, Jens Timmer, Przemyslaw Pisarski, Gunter Kirste & Gerd Walz. (2003) Expression profiling on chronically rejected transplant kidneys1. Transplantation 76:3, pages 539-547.
Crossref
Crossref
William J Hogan, Marie-Térèse Little, Eustacia Zellmer, Anke Friedetzky, Razvan Diaconescu, Serina Gisburne, Richard Lee, Christian Kuhr & Rainer Storb. (2003) Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates. Biology of Blood and Marrow Transplantation 9:8, pages 489-495.
Crossref
Crossref
AC Webster, G Higgins, JR Chapman & JC Craig. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
J Camardo. (2003) The Rapamune era of immunosuppression 2003: the journey from the laboratory to clinical transplantation. Transplantation Proceedings 35:3, pages S18-S24.
Crossref
Crossref
B Radovancevic & B Vrtovec. (2003) Sirolimus therapy in cardiac transplantation. Transplantation Proceedings 35:3, pages S171-S176.
Crossref
Crossref
C Ponticelli, A Tarantino, A Aroldi, V Sparacino, S Stefoni, F Citterio, L Duca, M.P Scolari, S Calabrese, P Altieri, G Civati & B Cesana. (2003) Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine. Transplantation Proceedings 35:3, pages S62-S63.
Crossref
Crossref
Ryan A. McTaggart, Danielle Gottlieb, Jessica Brooks, Peter Bacchetti, John P. Roberts, Stephen Tomlanovich & Sandy Feng. (2003) Sirolimus Prolongs Recovery from Delayed Graft Function After Cadaveric Renal Transplantation. American Journal of Transplantation 3:4, pages 416-423.
Crossref
Crossref
Robert I. Lechler, Oliver A. Garden & Laurence A. Turka. (2003) The complementary roles of deletion and regulation in transplantation tolerance. Nature Reviews Immunology 3:2, pages 147-158.
Crossref
Crossref
M.-K Tsai, R.-H Hu & P.-H Lee. (2003) Sirolimus antirejection therapy for renal transplantation with cyclosporine-based immunosuppression: case reports. Transplantation Proceedings 35:1, pages 219-220.
Crossref
Crossref
Dominique Debray, V??lerie Furlan, V??ronique Baudouin, Lucile Houyel, Florence Lacaille & Christophe Chardot. (2003) Therapy for Acute Rejection in Pediatric Organ Transplant Recipients. Pediatric Drugs 5:2, pages 81-93.
Crossref
Crossref
Dominique Debray, V??lerie Furlan, V??ronique Baudouin, Lucile Houyel, Florence Lacaille & Christophe Chardot. (2003) Therapy for Acute Rejection in Pediatric Organ Transplant Recipients. Pediatric Drugs 5:2, pages 81-93.
Crossref
Crossref
José M. Morales. (2002) Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Kidney International 62, pages S81-S87.
Crossref
Crossref
Nasimul Ahsan & K. Venkateswara Rao. (2002) Renal Transplantation Update
Series Editors: V. Ram Peddi and M. Roy First: Hepatobiliary Diseases After Kidney Transplantation Unrelated to Classic Hepatitis Virus. Seminars in Dialysis 15:5, pages 358-365.
Crossref
Crossref
Jean C Emond. (2002) What’s New in Transplantation. Journal of the American College of Surgeons 194:5, pages 636-641.
Crossref
Crossref